Chitosan-Coated Liposomes for Lysozyme-Triggered Antibiotic Release

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Conventional antibacterial drugs face limitations due to low bioavailability, limited penetration to infection sites, and the rise of drug-resistant bacteria, leading to ineffective therapeutic efficacy and potential side effects.

Innovation Solution

Development of polysaccharide-coated liposomes, specifically chitosan-coated liposomes, that encapsulate antibiotics like levofloxacin, designed for on-demand release in lysozyme-rich environments to enhance therapeutic efficacy and reduce drug resistance.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If conventional antibiotics are used for antibacterial therapy, then the treatment can be administered systemically, but the bioavailability is low and penetration to infection sites is limited

Engineering Contradiction:

ImprovebioavailabilityVSAvoiddelivery system complexity

Core Design Contradiction:

Quantity of substanceVSDevice complexity

Solution Approach 1:

The patent employs liposomes as intermediary carriers that encapsulate antibiotics, enabling improved bioavailability and targeted delivery to infection sites. The liposome acts as a mediator between the administered drug and the infection site, protecting the antibiotic from degradation and facilitating penetration through biological barriers.

Inventive Principle:

Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent utilizes liposomal membranes as flexible shells that can adapt to different biological environments. These thin film structures allow the antibiotic payload to be delivered while maintaining stability in circulation, and the shells can be engineered with specific properties to enhance penetration to infection sites.

Inventive Principle:

Principle #30Flexible shells and thin films

2Adaptability or versatility

If conventional antibiotics are used to treat infections, then the treatment can be administered broadly, but drug-resistant bacteria emerge

Engineering Contradiction:

Improvetreatment broadnessVSAvoidtherapeutic efficacy

Core Design Contradiction:

Adaptability or versatilityVSReliability

Solution Approach 1:

The patent implements local quality by designing liposomes that can be targeted to specific infection sites rather than providing uniform systemic distribution. This allows high concentrations of antibiotic to be delivered locally where needed, improving therapeutic efficacy and reducing selective pressure for resistance development in other areas.

Inventive Principle:

Principle #3Local quality

Solution Approach 2:

The patent incorporates dynamic elements through stimuli-responsive liposome designs that can change their properties in response to environmental cues at infection sites. This dynamic behavior allows the delivery system to adapt to different infection conditions and release antibiotics in a controlled manner, enhancing therapeutic reliability.

Inventive Principle:

Principle #15Dynamics

3Adaptability or versatility

If antibiotics are delivered systemically to ensure coverage, then all infection sites can be treated, but side effects increase

Engineering Contradiction:

Improveinfection site coverageVSAvoidside effects

Core Design Contradiction:

Adaptability or versatilityVSObject-affected harmful factors

Solution Approach 1:

The patent applies segmentation by dividing the systemic circulation into targeted delivery pathways through liposome-mediated transport. Instead of uniform distribution, the system segments the drug delivery to specific tissues and infection sites, reducing exposure of healthy tissues to the antibiotic and thereby minimizing side effects while maintaining effective coverage at infection locations.

Inventive Principle:

Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The system enhances antibiotic delivery to infection sites, reduces drug resistance, and minimizes side effects by providing controlled and targeted drug release in response to lysozyme activity.

Implementation Method 1

the polysaccharide is degradable by a lysozyme and/or forms a conjugate with the lysozyme

Methodology Applied

Scientific EffectEnzymatic degradation: Enzyme

Implementation Method 2

designed for on-demand release in lysozyme-rich environments

Methodology Applied

Scientific EffectLysozyme activity: Enzyme

Implementation Method 3

a polysaccharide-coated liposome and a composition comprising the polysaccharide-coated liposome and a pharmaceutically acceptable carrier or excipient

Methodology Applied

Scientific EffectEncapsulation: Physical Containment

Implementation Method 4

enhances antibiotic delivery to infection sites

Methodology Applied

Scientific EffectLiposome transport: Permeation

Data Source

PatentUS20250332102A1On-demand release of antibiotic composition and method for treating infections

Publication Date: 2025.10.30 ANTINOUS TECHNOLOGY CO LTD

AI summary

Disclosed herein in some aspects are a polysaccharide-coated liposome and a composition comprising the polysaccharide-coated liposome and a pharmaceutically acceptable carrier or excipient. In some embodiments, disclosed herein is a chitosan-coated liposome with lysozyme-responsive properties for on-demand release of an antibiotic encapsulated therein in a lysozyme-rich environment while maintaining the stability of the liposome in a lysozyme-deficient environment.